A genetic model for central chondrosarcoma evolution correlates with patient outcome
Abstract Background Central conventional chondrosarcoma (CS) is the most common subtype of primary malignant bone tumour in adults. Treatment options are usually limited to surgery, and prognosis is challenging. These tumours are characterised by the presence and absence of IDH1 and IDH2 mutations,...
Principais autores: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
BMC
2022-08-01
|
coleção: | Genome Medicine |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1186/s13073-022-01084-0 |